Skip to content
How It Works
Explore
Ask a Question Resources Pricing
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Sign Up
PubMed This is a summary of 40 peer-reviewed journal articles Updated
Breast Surgery · Breast Cancer

How Do I Choose Lumpectomy vs Mastectomy for Breast Cancer?

At a Glance

For appropriately selected people with early-stage breast cancer, lumpectomy followed by radiation and mastectomy offer equivalent overall survival. The choice depends on tumor size and location, genetic risk, radiation needs, recovery, body image, sensation, and personal preferences.

In this answer

6 sections

01

Survival and Recurrence Risks

02

Tumor Size, Location, and Lymph Nodes

03

The Misconception About Mastectomy and Further Treatments

04

Genetic Risk Factors

05

Recovery, Sensation, and Reconstruction

06

Future Surveillance and “Scanxiety”

When deciding between a lumpectomy and a mastectomy for early-stage breast cancer, the most important fact to know is that both options offer equivalent long-term overall survival for appropriately selected patients [1][2]. However, “equivalent survival” does not mean identical treatment experiences or identical recurrence risks.

A lumpectomy (often called breast-conserving surgery) removes the tumor and a margin of healthy tissue, and is generally followed by radiation. A mastectomy removes the entire breast. The choice depends on your tumor’s characteristics, your breast anatomy, genetic risk factors, and your personal preferences regarding recovery, body image, and future surveillance [3][4].

Survival and Recurrence Risks

While overall survival is the same, local recurrence rates differ slightly. Breast-conserving surgery followed by radiation has a somewhat higher risk of the cancer returning in the treated breast compared to a mastectomy, though the absolute risk remains low [1][5]. Mastectomy significantly lowers the risk of local recurrence but does not make it zero, as cancer can sometimes return in the chest wall or skin [6].

Tumor Size, Location, and Lymph Nodes

The location of your tumor in the upper-outer quadrant (the area closest to the armpit) can sometimes be favorable for a lumpectomy, as this area often has more tissue. However, cosmetic outcomes depend heavily on the tumor’s depth, its size relative to your breast, and your natural breast shape [7]. Because this area is near the armpit, tissue removal might cause visible contour changes or asymmetry.

Regardless of the surgery you choose, your surgical team will likely perform a sentinel lymph node biopsy to check if cancer has spread to the lymph nodes in your armpit. This staging helps guide further treatment but carries a risk of arm numbness or swelling (lymphedema) [8].

Surgeons must also evaluate the tumor-to-breast size ratio. If your tumor is large, or if you have multiple tumors in different areas (multifocal or multicentric disease), a mastectomy might be recommended to ensure clear margins (meaning no cancer cells are seen at the outer edge of the removed tissue) [9][10]. However, specialized oncoplastic surgery (combining cancer removal with plastic surgery techniques) can sometimes allow patients with larger or multiple tumors to safely have a lumpectomy [11][12].

It is important to know that a lumpectomy sometimes requires a second surgery (re-excision) if the initial margins are not clear [10]. Furthermore, extensive diffuse calcifications, inflammatory breast cancer, or prior chest radiation might make you medically ineligible for a lumpectomy [13].

The Misconception About Mastectomy and Further Treatments

A common myth is that choosing a mastectomy guarantees you will not need radiation or systemic therapies (like chemotherapy or hormone-blocking pills).

  • Systemic Therapy: The need for chemotherapy, targeted therapy, or endocrine (hormone-blocking) therapy is based on the tumor’s specific biology—such as its grade, hormone-receptor status (whether it uses estrogen to grow), HER2 status, genomic tests, and lymph node involvement. The type of breast surgery you choose does not dictate your systemic therapy [14][15].
  • Radiation: Lumpectomy is standardly followed by radiation to prevent the cancer from returning [16]. Today, radiation schedules vary; while older protocols took several weeks, modern shortened (hypofractionated) schedules can take anywhere from one to a few weeks, depending on your specific case [17]. In carefully selected older patients with small, hormone-positive tumors, radiation might sometimes be omitted entirely [18][19].

Crucially, a mastectomy does not automatically rule out radiation. Depending on individual risk factors—such as having a large tumor, positive lymph nodes, skin involvement, or close margins—your radiation oncologist may still strongly recommend post-mastectomy radiation [20][21][22].

Genetic Risk Factors

If genetic testing reveals a high-risk mutation, such as BRCA1 or BRCA2, a lumpectomy with radiation remains an oncologically effective option for treating your current cancer [23]. However, these mutations carry a high risk of developing a brand-new breast cancer in the future, either in the same breast or the opposite one [24][25]. For this reason, guidelines suggest patients with these mutations receive genetic counseling to discuss a bilateral (double) mastectomy to manage future risk [23][26]. A bilateral mastectomy drastically reduces, but does not completely eliminate, the risk of a new breast cancer [27].

Recovery, Sensation, and Reconstruction

  • Lumpectomy: This is a shorter surgery with a faster recovery time [28]. It generally provides much better preservation of nipple sensation, and is associated with better long-term body image and sexual well-being compared to a mastectomy [29][30][31].
  • Mastectomy: Recovery involves surgical drains, wound management, and a longer healing period. You can choose to “go flat” (no reconstruction) or opt for immediate or delayed reconstruction [32]. Autologous reconstruction (using your own tissue from areas like the abdomen) often feels more natural but involves a significantly longer surgery, potential donor-site complications, and a longer recovery [33][34]. Implant reconstruction is a shorter surgery but carries risks like implant failure, capsular contracture, or the need for future revision [34][35].

Mastectomy generally results in a significant or total loss of breast and nipple sensation. While specialized nerve-grafting techniques (neurotization) are evolving, they are not universally available and do not guarantee restored feeling [32][36].

Future Surveillance and “Scanxiety”

After a lumpectomy, you will continue with routine mammograms on both breasts to monitor for any recurrence [37][38]. Additional imaging, like an MRI, is not automatic but may be recommended if you have dense breasts or genetic risk factors [39].

If you have a unilateral (single) mastectomy, the remaining breast will still require regular mammograms. After a bilateral mastectomy, routine screening mammograms are usually no longer performed, which can relieve the anxiety surrounding routine scans (often called “scanxiety”) [40]. However, you will still need regular clinical exams to check the chest wall, skin, and reconstructed areas for any new symptoms.

Common questions in this guide

Does a lumpectomy or mastectomy provide better survival for early-stage breast cancer?
For appropriately selected people with early-stage breast cancer, lumpectomy followed by radiation and mastectomy offer equivalent long-term overall survival. They differ in recovery, breast sensation, follow-up care, and the chance of cancer returning in the treated breast or chest area, so the best choice depends on medical factors and personal priorities.
Does an upper-outer quadrant tumor make lumpectomy a better option?
The upper-outer area is near the armpit and may contain enough tissue for a good lumpectomy result, but location alone does not determine the choice. Tumor size, depth, breast size and shape, and the ability to remove the tumor with clear edges also matter. Oncoplastic surgery, which combines cancer removal with plastic-surgery techniques, may improve the result in some cases.
Will I still need radiation or chemotherapy after a mastectomy?
Possibly. The need for chemotherapy, targeted treatment, or hormone-blocking treatment depends on the tumor’s biology, hormone and HER2 status, genomic testing, and lymph-node findings—not simply the operation. Radiation may still be recommended after mastectomy for features such as a large tumor, involved lymph nodes, skin involvement, or close edges of the removed tissue.
Do I always need radiation after a lumpectomy?
Radiation is usually recommended after lumpectomy to lower the chance of cancer returning in the treated breast. Shorter schedules may be appropriate, and carefully selected older adults with small tumors that use hormones to grow may sometimes omit radiation. A radiation oncologist determines the schedule based on your tumor features and overall risk.
Should I choose a double mastectomy if I have a BRCA1 or BRCA2 mutation?
A lumpectomy followed by radiation can effectively treat the current breast cancer in someone with a BRCA1 or BRCA2 mutation. These mutations also raise the chance of a new breast cancer in either breast, so genetic counseling can help you weigh bilateral mastectomy against breast conservation. Bilateral mastectomy greatly lowers, but does not eliminate, that future risk.
How do recovery and breast sensation differ between the two surgeries?
Lumpectomy is usually a shorter operation with a faster recovery and better preservation of breast and nipple sensation. Mastectomy generally involves a longer healing period and may include drains, reconstruction, or choosing no reconstruction, sometimes called going flat. It often causes substantial or complete loss of breast and nipple sensation, and reconstruction can add surgery, recovery time, and possible complications.
What follow-up imaging or additional surgery might I need?
After lumpectomy, a second operation may be needed if the edges of the removed tissue are not clear, and routine mammograms are usually performed on both breasts. After a unilateral mastectomy, the remaining breast still needs regular mammograms. After bilateral mastectomy, routine screening mammograms are usually not performed, but regular clinical exams remain important.

Related questions

What Do HER2 2+ or Discordant Results Mean in Breast Cancer? How Are Multifocal, Multicentric Breast Cancers Diagnosed? When Can I Resume Exercise After Breast Cancer Surgery? How Is a Breast or Armpit Lump Evaluated for Breast Cancer? How Is an Axillary-Tail Tumor Staged in Breast Cancer?
Show more
What Do Breast Cancer Stage Labels Mean? TNM & Prognostic What Does No Ink on Tumor Mean for Lumpectomy Margins? When Is Breast MRI Recommended Before Breast Cancer Surgery? How Does Invasive Lobular Differ From Ductal Breast Cancer? Should a Suspicious Armpit Node Be Biopsied First? How Does Radiation Affect Breast Reconstruction Choices? ER-Low Positive Breast Cancer: Is Endocrine Therapy Needed? What Does LVI Mean in Upper-Outer Quadrant Breast Cancer? When Are Oncotype DX and MammaPrint Used in Breast Cancer? Can Oncoplastic Surgery Improve Shape After Lumpectomy? How Is DCIS Treated Differently From Invasive Breast Cancer? How Is Ki-67 Interpreted in Upper-Outer Breast Cancer? What to Expect: Sentinel Lymph Node Biopsy for Breast Cancer When Can I Skip Axillary Dissection After Positive Nodes?

Get notified when new evidence is published on female breast upper-outer quadrant cancer.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (40)
  1. 1

    Decision Making in the Surgical Management of Invasive Breast Cancer-Part 2: Expanded Applications for Breast-Conserving Surgery.

    Newman LA

    Oncology (Williston Park, N.Y.) 2017; (31(5)):415-20.

    PMID: 28516441
  2. 2

    Overall survival after mastectomy versus breast-conserving surgery with adjuvant radiotherapy for early-stage breast cancer: meta-analysis.

    Rajan KK, Fairhurst K, Birkbeck B, et al.

    BJS open 2024; (8(3)) doi:10.1093/bjsopen/zrae040.

    PMID: 38758563
  3. 3

    Personalized Breast Reconstruction After Breast-Conserving Therapy: Risk-Informed Approaches to Technique Selection and Timing.

    Sorenson TJ, Boyd CJ, Lisk R, Karp NS

    Journal of personalized medicine 2026; (16(4)) doi:10.3390/jpm16040197.

    PMID: 42042564
  4. 4

    Health-related quality of life following mastectomy and lumpectomy evaluated with the BREAST-Q and RAND-36.

    van der Veen JE, Visser E, Hendrickx AA, et al.

    Surgical oncology 2026; (68()):102529 doi:10.1016/j.suronc.2026.102529.

    PMID: 42561870
  5. 5

    Breast conserving surgery combined with radiation therapy offers improved survival over mastectomy in early-stage breast cancer.

    Vasilyeva E, Nichol A, Bakos B, et al.

    American journal of surgery 2024; (231()):70-73 doi:10.1016/j.amjsurg.2023.05.005.

    PMID: 37246127
  6. 6

    Long-Term Oncologic Safety of Nipple-Sparing Mastectomy With Immediate Reconstruction.

    Yamashita Y, Tsunoda H, Nagura N, et al.

    Clinical breast cancer 2021; (21(4)):352-359 doi:10.1016/j.clbc.2021.01.002.

    PMID: 33526379
  7. 7

    Objective decision making between conventional and oncoplastic breast-conserving surgery or mastectomy: An aesthetic and functional prospective cohort study.

    Pukancsik D, Kelemen P, Újhelyi M, et al.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2017; (43(2)):303-310 doi:10.1016/j.ejso.2016.11.010.

    PMID: 28069398
  8. 8

    Novel radiation therapy approaches for breast cancer treatment.

    Shah C, Bauer-Nilsen K, McNulty RH, Vicini F

    Seminars in oncology 2020; (47(4)):209-216 doi:10.1053/j.seminoncol.2020.05.003.

    PMID: 32513420
  9. 9

    Breast Cancer Surgery at a Tertiary Center in Greece: Clinicopathological Associations and Patient Outcomes.

    Flindris S, Margioula-Siarkou C, Margioula-Siarkou G, et al.

    Cureus 2025; (17(7)):e87546 doi:10.7759/cureus.87546.

    PMID: 40777673
  10. 10

    Clinical and patient-reported outcomes in women offered oncoplastic breast-conserving surgery as an alternative to mastectomy: ANTHEM multicentre prospective cohort study.

    Davies C, Johnson L, Conefrey C, et al.

    The British journal of surgery 2024; (112(1)) doi:10.1093/bjs/znae306.

    PMID: 39718969
  11. 11

    Oncoplastic breast surgery: comprehensive review.

    Bertozzi N, Pesce M, Santi PL, Raposio E

    European review for medical and pharmacological sciences 2017; (21(11)):2572-2585.

    PMID: 28678328
  12. 12

    Breast-Conserving Surgery in Multicentric Breast Cancer: Evolving Evidence and Patient Selection.

    Rizk M, Mokbel K

    Cancers 2026; (18(16)) doi:10.3390/cancers18162705.

    PMID: 42650016
  13. 13

    Analysis of low-benefit subgroups in breast-conserving surgery: Implications for clinical decision-making (Review).

    Lin W, Luo L, Guo G, Lin H

    Experimental and therapeutic medicine 2026; (31(6)):155 doi:10.3892/etm.2026.13150.

    PMID: 42051865
  14. 14

    Adjuvant Radiotherapy in Early-Stage Breast Cancer: Evidence-Based Options.

    Shah C, Tendulkar R, Smile T, et al.

    Annals of surgical oncology 2016; (23(12)):3880-3890 doi:10.1245/s10434-016-5503-x.

    PMID: 27557828
  15. 15

    Breast Cancer: An Overview of Current Therapeutic Strategies, Challenge, and Perspectives.

    Wang J, Wu SG

    Breast cancer (Dove Medical Press) 2023; (15()):721-730 doi:10.2147/BCTT.S432526.

    PMID: 37881514
  16. 16

    Postoperative Radiotherapy After Breast-Conserving Surgery for Early-Stage Breast Cancer: A Review.

    Speers C, Pierce LJ

    JAMA oncology 2016; (2(8)):1075-82 doi:10.1001/jamaoncol.2015.5805.

    PMID: 27243924
  17. 17

    Update on Accelerated Whole Breast Irradiation.

    Shah C, Fleming-Hall E, Asha W

    Clinical breast cancer 2023; (23(3)):237-240 doi:10.1016/j.clbc.2023.01.011.

    PMID: 36792457
  18. 18

    Surgeon and Radiation Oncologist Views on Omission of Adjuvant Radiotherapy for Older Women with Early-Stage Breast Cancer.

    Shumway DA, Griffith KA, Sabel MS, et al.

    Annals of surgical oncology 2017; (24(12)):3518-3526 doi:10.1245/s10434-017-6013-1.

    PMID: 28748445
  19. 19

    Lumpectomy Plus Hormone or Radiation Therapy Alone for Women Aged 70 Years or Older With Hormone Receptor-Positive Early Stage Breast Cancer in the Modern Era: An Analysis of the National Cancer Database.

    Buszek SM, Lin HY, Bedrosian I, et al.

    International journal of radiation oncology, biology, physics 2019; (105(4)):795-802 doi:10.1016/j.ijrobp.2019.07.052.

    PMID: 31377160
  20. 20

    Postmastectomy radiation therapy in early breast cancer: Utility or futility?

    Montero A, Ciérvide R, García-Aranda M, Rubio C

    Critical reviews in oncology/hematology 2020; (147()):102887 doi:10.1016/j.critrevonc.2020.102887.

    PMID: 32018127
  21. 21

    Multidisciplinary international survey of post-operative radiation therapy practices after nipple-sparing or skin-sparing mastectomy.

    Marta GN, Poortmans P, de Barros AC, et al.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2017; (43(11)):2036-2043 doi:10.1016/j.ejso.2017.09.014.

    PMID: 28967564
  22. 22

    Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer: ASCO Guideline Update.

    Park KU, Somerfield MR, Anne N, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2025; (43(14)):1720-1741 doi:10.1200/JCO-25-00099.

    PMID: 40209128
  23. 23

    Management of Hereditary Breast Cancer: American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Guideline.

    Tung NM, Boughey JC, Pierce LJ, et al.

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2020; (38(18)):2080-2106 doi:10.1200/JCO.20.00299.

    PMID: 32243226
  24. 24

    Breast-conserving therapy for breast cancer with BRCA mutations: a meta-analysis.

    Wang C, Lin Y, Zhu H, et al.

    Breast cancer (Tokyo, Japan) 2022; (29(2)):314-323 doi:10.1007/s12282-021-01312-2.

    PMID: 34766244
  25. 25

    Long-Term Oncologic Outcome of Breast-Conserving Treatment in Patients With Breast Cancer With BRCA Variants.

    Lee J, Ryu JM, Kim HK, et al.

    JAMA network open 2025; (8(5)):e259840 doi:10.1001/jamanetworkopen.2025.9840.

    PMID: 40366658
  26. 26

    Comparison of Outcomes Between BRCA Pathogenic Variant Carriers Undergoing Breast-Conserving Surgery Versus Mastectomy.

    Shubeck S, Sevilimedu V, Berger E, et al.

    Annals of surgical oncology 2022; (29(8)):4706-4713 doi:10.1245/s10434-022-11756-1.

    PMID: 35585432
  27. 27

    Bilateral Mastectomy and Breast Cancer Mortality.

    Giannakeas V, Lim DW, Narod SA

    JAMA oncology 2024; (10(9)):1228-1236 doi:10.1001/jamaoncol.2024.2212.

    PMID: 39052262
  28. 28

    Patient-reported longitudinal symptom patterns following breast-conserving surgery versus mastectomy with or without immediate breast reconstruction: A retrospective cohort study.

    Zeng H, Nguyen L, He J, et al.

    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 2026; (52(10)):112055 doi:10.1016/j.ejso.2026.112055.

    PMID: 42580202
  29. 29

    Impact of breast reconstruction on sexual function and body image in breast cancer survivors: A systematic review.

    Triantafyllou M, Michalopoulos N

    JPRAS open 2026; (51()):22-35 doi:10.1016/j.jpra.2026.05.056.

    PMID: 42376013
  30. 30

    Comparing Quality of Life in Breast Cancer Patients Who Underwent Mastectomy Versus Breast-Conserving Surgery: A Meta-Analysis.

    Ng ET, Ang RZ, Tran BX, et al.

    International journal of environmental research and public health 2019; (16(24)) doi:10.3390/ijerph16244970.

    PMID: 31817811
  31. 31

    Comparison of Long-Term Health-Related Quality of Life After Mastectomy and Breast Conserving Therapy.

    Järvinen S, Jahkola T, Ihalainen H, et al.

    World journal of surgery 2026; (50(10)):2787-2795 doi:10.1002/wjs.70517.

    PMID: 42687343
  32. 32

    [Update and Trends in Breast Reconstruction After Mastectomy].

    Supper P, Semmler L, Placheta-Györi E, et al.

    Handchirurgie, Mikrochirurgie, plastische Chirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Handchirurgie : Organ der Deutschsprachigen Arbeitsgemeinschaft fur Mikrochirurgie der Peripheren Nerven und Gefasse : Organ der V... 2023; (55(4)):253-261 doi:10.1055/a-2082-1542.

    PMID: 37487507
  33. 33

    A review of different breast reconstruction methods.

    Song Y, Zeng J, Tian X, et al.

    American journal of translational research 2023; (15(6)):3846-3855.

    PMID: 37434844
  34. 34

    Implant-based versus Autologous Reconstruction after Mastectomy for Breast Cancer: A Systematic Review and Meta-analysis.

    Broyles JM, Balk EM, Adam GP, et al.

    Plastic and reconstructive surgery. Global open 2022; (10(3)):e4180 doi:10.1097/GOX.0000000000004180.

    PMID: 35291333
  35. 35

    Breast Reconstruction Following Cancer Treatment.

    Gerber B, Marx M, Untch M, Faridi A

    Deutsches Arzteblatt international 2015; (112(35-36)):593-600.

    PMID: 26377531
  36. 36

    The Evolution of Implant-Based Breast Reconstruction: Innovations, Trends, and Future Directions.

    Amro C, Sorenson TJ, Boyd CJ, et al.

    Journal of clinical medicine 2024; (13(23)) doi:10.3390/jcm13237407.

    PMID: 39685866
  37. 37

    Breast Cancer Surveillance in Patients with a Personal History of Breast Cancer: Updates and Controversies.

    Chikarmane SA, Giess CS

    Radiographics : a review publication of the Radiological Society of North America, Inc 2025; (45(4)):e240132 doi:10.1148/rg.240132.

    PMID: 40146628
  38. 38

    Imaging Surveillance Options for Individuals With a Personal History of Breast Cancer: AJR Expert Panel Narrative Review.

    Lawson MB, Herschorn SD, Sprague BL, et al.

    AJR. American journal of roentgenology 2022; (219(6)):854-868 doi:10.2214/AJR.22.27635.

    PMID: 35544374
  39. 39

    Breast Cancer Screening for Women at Higher-Than-Average Risk: Updated Recommendations From the ACR.

    Monticciolo DL, Newell MS, Moy L, et al.

    Journal of the American College of Radiology : JACR 2023; (20(9)):902-914 doi:10.1016/j.jacr.2023.04.002.

    PMID: 37150275
  40. 40

    Variability of Postsurgical Imaging Surveillance of Breast Cancer Patients: A Nationwide Survey Study.

    Patel BK, Lee CS, Kosiorek HE, et al.

    AJR. American journal of roentgenology 2018; (210(1)):222-227 doi:10.2214/AJR.17.17923.

    PMID: 29064749

This comparison of lumpectomy and mastectomy is for informational purposes only and does not constitute medical advice. Discuss your tumor findings, genetic results, treatment goals, and reconstruction options with your breast cancer team.